AQR Capital Management’s Histogen Inc. Common Stock HSTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-1,650
Closed -$1.94M 2406
2018
Q1
$1.94M Sell
1,650
-2,021
-55% -$2.23M ﹤0.01% 1374
2017
Q4
$3.39M Buy
3,671
+2,046
+126% +$1.89M ﹤0.01% 1165
2017
Q3
$1.78M Buy
1,625
+1,463
+903% +$1.66M ﹤0.01% 1420
2017
Q2
$187K Buy
+162
New +$197K ﹤0.01% 2137

Other funds holding HSTO

AQR Capital Management's HSTO Position: Q2 2018 in Review

AQR Capital Management sold out of Histogen Inc. Common Stock (HSTO) in Q2 2018, closing a stake of 1,650 shares — an estimated $1.94M sold.

AQR Capital Management first reported a position in HSTO in Q2 2017 and held it in 4 quarters. The position peaked at $3.39M in Q4 2017. 61 funds tracked by Wall St. Rank hold HSTO as of Q2 2018.

  • AQR Capital Management reported no remaining Histogen Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • AQR Capital Management sold 1,650 Histogen Inc. Common Stock shares in Q2 2018, an estimated $1.94M.
  • AQR Capital Management first reported a position in Histogen Inc. Common Stock in Q2 2017 and held it in 4 quarters.
  • AQR Capital Management's Histogen Inc. Common Stock position peaked at $3.39M in Q4 2017.
  • 61 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q2 2018.

Based on AQR Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.